MEP12608A - N-(fenil (2-pirodinil) benzamid i n-(2-azepanil) fenil metil/benzamid derivati, njihovo dobijanje i terapeutska primjena - Google Patents

N-(fenil (2-pirodinil) benzamid i n-(2-azepanil) fenil metil/benzamid derivati, njihovo dobijanje i terapeutska primjena

Info

Publication number: MEP12608A
Authority: ME; Montenegro
Prior art keywords: benzamide; alkyl; pyrrolidine; phenyl; compounds
Prior art date: 2003-10-17

Application number

MEP-126/08A

Other languages

Bosnian (bs)

English (en)

Inventor

Gihad Dargazanli

Genevieve Estenne-Bouhtou

Florence Medaisko

Nathalie Rakotoarisoa

Original Assignee

Sanofi Aventis

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-10-17

Filing date

2004-10-15

Publication date

2010-06-10

2004-10-15 Application filed by Sanofi Aventis filed Critical Sanofi Aventis

2010-06-10 Publication of MEP12608A publication Critical patent/MEP12608A/hr

Links

125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 title abstract 2
-1 pyrrolidine-2-yl Chemical group 0.000 title abstract 2
KXDAEFPNCMNJSK-UHFFFAOYSA-N Benzamide Chemical compound NC(=O)C1=CC=CC=C1 KXDAEFPNCMNJSK-UHFFFAOYSA-N 0.000 title 4
125000004320 azepan-2-yl group Chemical group [H]N1C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C1([H])* 0.000 title 1
125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 title 1
239000003814 drug Substances 0.000 title 1
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 title 1
238000002360 preparation method Methods 0.000 title 1
125000000217 alkyl group Chemical group 0.000 abstract 4
RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 abstract 3
150000001875 compounds Chemical class 0.000 abstract 3
NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 abstract 2
125000003545 alkoxy group Chemical group 0.000 abstract 2
125000000753 cycloalkyl group Chemical group 0.000 abstract 2
125000005843 halogen group Chemical group 0.000 abstract 2
125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
125000001424 substituent group Chemical group 0.000 abstract 2
125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 2
YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical group C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 abstract 1
239000002253 acid Substances 0.000 abstract 1
125000003342 alkenyl group Chemical group 0.000 abstract 1
125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 1
125000004390 alkyl sulfonyl group Chemical group 0.000 abstract 1
125000000304 alkynyl group Chemical group 0.000 abstract 1
125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 abstract 1
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
125000001316 cycloalkyl alkyl group Chemical group 0.000 abstract 1
229910052757 nitrogen Inorganic materials 0.000 abstract 1
125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
125000003884 phenylalkyl group Chemical group 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
239000012453 solvate Substances 0.000 abstract 1
230000001225 therapeutic effect Effects 0.000 abstract 1
125000004001 thioalkyl group Chemical group 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D223/04—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with only hydrogen atoms, halogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
- C07D207/09—Radicals substituted by nitrogen atoms, not forming part of a nitro radical

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Reproductive Health (AREA)
Endocrinology (AREA)
Addiction (AREA)
Psychology (AREA)
Physical Education & Sports Medicine (AREA)
Rheumatology (AREA)
Diabetes (AREA)
Hospice & Palliative Care (AREA)
Child & Adolescent Psychology (AREA)
Hematology (AREA)
Obesity (AREA)
Pulmonology (AREA)
Gynecology & Obstetrics (AREA)
Pregnancy & Childbirth (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Pyrrole Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

MEP-126/08A 2003-10-17 2004-10-15 N-(fenil (2-pirodinil) benzamid i n-(2-azepanil) fenil metil/benzamid derivati, njihovo dobijanje i terapeutska primjena MEP12608A (hr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR0312143A FR2861070B1 (fr)	2003-10-17	2003-10-17	Derives de n-[phenyl(pyrrolidin-2-yl)methyl]benzamide et n-[(azepan-2-yl)phenylmethyl]benzamide, leur preparation et leur application en therapeutique
PCT/FR2004/002644 WO2005037785A2 (fr)	2003-10-17	2004-10-15	Derives de n-[phenyl(pyrrolidin-2-yl)methyl]benzamide, et n-[azepan-2-yl) phenylmethyl]benzamide, leur preparation et leur application en therapeutique

Publications (1)

Publication Number	Publication Date
MEP12608A true MEP12608A (hr)	2010-06-10

Family

ID=34385236

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MEP-126/08A MEP12608A (hr)	2003-10-17	2004-10-15	N-(fenil (2-pirodinil) benzamid i n-(2-azepanil) fenil metil/benzamid derivati, njihovo dobijanje i terapeutska primjena

Country Status (25)

Country	Link
US (2)	US7226917B2 (hr)
EP (1)	EP1680400B1 (hr)
JP (1)	JP4700007B2 (hr)
CN (1)	CN1882534A (hr)
AT (1)	ATE364038T1 (hr)
AU (1)	AU2004281218B2 (hr)
BR (1)	BRPI0415511A (hr)
CA (1)	CA2542727A1 (hr)
CY (1)	CY1106827T1 (hr)
DE (1)	DE602004006891T2 (hr)
DK (1)	DK1680400T3 (hr)
ES (1)	ES2286689T3 (hr)
FR (1)	FR2861070B1 (hr)
HR (1)	HRP20070307T3 (hr)
IL (1)	IL174934A (hr)
MA (1)	MA28098A1 (hr)
ME (1)	MEP12608A (hr)
NO (1)	NO20062032L (hr)
NZ (1)	NZ547167A (hr)
PL (1)	PL1680400T3 (hr)
PT (1)	PT1680400E (hr)
RS (1)	RS20060315A (hr)
RU (1)	RU2386614C2 (hr)
WO (1)	WO2005037785A2 (hr)
ZA (1)	ZA200603862B (hr)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2842804B1 (fr)	2002-07-29	2004-09-03	Sanofi Synthelabo	Derives de n-[phenyl(piperidin-2-yl)methyl]benzamide, leur preparation et leur application en therapeutique
FR2861071B1 (fr) *	2003-10-17	2006-01-06	Sanofi Synthelabo	Derives de n-[phenyl(alkylpiperidin-2-yl) methyl]benzamide, leur prepartation et leur application en therapeutique
FR2861070B1 (fr) *	2003-10-17	2006-01-06	Sanofi Synthelabo	Derives de n-[phenyl(pyrrolidin-2-yl)methyl]benzamide et n-[(azepan-2-yl)phenylmethyl]benzamide, leur preparation et leur application en therapeutique
FR2861074B1 (fr) *	2003-10-17	2006-04-07	Sanofi Synthelabo	Derives de n-[phenyl(piperidin-2-yl)methyl]benzamide, leur preparation et leur application en therapeutique
PE20061156A1 (es)	2004-12-23	2006-12-16	Glaxo Group Ltd	Derivados de benzamida como agentes inhibidores del transportador de glicina
GB0612420D0 (en) *	2006-06-22	2006-08-02	Glaxo Group Ltd	Compounds
CN101784533B (zh)	2007-08-22	2013-08-21	艾博特股份有限两合公司	4-苄基氨基喹啉、含有它们的药物组合物和它们在治疗中的用途
JP5554319B2 (ja)	2008-04-01	2014-07-23	アボットゲーエムベーハーウントカンパニーカーゲー	テトラヒドロイソキノリン類、それを含む医薬組成物および治療におけるそれの使用
CN102405222A (zh) *	2009-01-28	2012-04-04	阿斯利康(瑞典)有限公司	2-氮杂-二环[2.2.1]庚烷化合物及其用途
FR2941954B1 (fr) *	2009-02-10	2011-04-08	Sanofi Aventis	Derives de n-°(6-aza-bicyclo°3.2.1!oct-1-yl)-aryl-methyl! benzamide, leur preparation et leur application en therapeutique
FR2941953B1 (fr) *	2009-02-10	2011-04-08	Sanofi Aventis	Derives de n-°(2-aza-bicyclo°2.1.1!hex-1-yl)-benzamide, leur preparation et leur application en therapeutique
AR075442A1 (es)	2009-02-16	2011-03-30	Abbott Gmbh & Co Kg	Derivados de aminotetralina, composiciones farmaceuticas que las contienen y sus usos en terapia
TW201038569A (en)	2009-02-16	2010-11-01	Abbott Gmbh & Co Kg	Heterocyclic compounds, pharmaceutical compositions containing them, and their use in therapy
CA2755526A1 (fr) *	2009-03-16	2010-09-23	Sanofi	Derives de n-[(2-aza-bicyclo[2.1.1]hex-1-yl)-aryl-methyl]-heterobenzamide, leur preparation et leur application en therapeutique
FR2943056A1 (fr) *	2009-03-16	2010-09-17	Sanofi Aventis	Derives de n-°2-aza-bicyclo°2.1.1!hex-1-yl)-aryl-methyl!- heterobenzamide, leur preparation et leur application en therapeutique
US8883839B2 (en)	2010-08-13	2014-11-11	Abbott Laboratories	Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy
US9045459B2 (en)	2010-08-13	2015-06-02	AbbVie Deutschland GmbH & Co. KG	Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy
US8846743B2 (en)	2010-08-13	2014-09-30	Abbott Laboratories	Aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy
US9051280B2 (en)	2010-08-13	2015-06-09	AbbVie Deutschland GmbH & Co. KG	Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy
US8877794B2 (en)	2010-08-13	2014-11-04	Abbott Laboratories	Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy
US9309200B2 (en)	2011-05-12	2016-04-12	AbbVie Deutschland GmbH & Co. KG	Benzazepine derivatives, pharmaceutical compositions containing them, and their use in therapy
US8853196B2 (en)	2011-08-05	2014-10-07	AbbVie Deutschland GmbH & Co. KG	Aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives, pharmaceutical compositions containing them, and their use in therapy
US8846741B2 (en)	2011-11-18	2014-09-30	Abbvie Inc.	N-substituted aminobenzocycloheptene, aminotetraline, aminoindane and phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy
US9365512B2 (en)	2012-02-13	2016-06-14	AbbVie Deutschland GmbH & Co. KG	Isoindoline derivatives, pharmaceutical compositions containing them, and their use in therapy
CN102692463A (zh) *	2012-06-13	2012-09-26	山东凯盛新材料股份有限公司	高效液相色谱法检测芳香族酰氯类产品的方法
US9650334B2 (en)	2013-03-15	2017-05-16	Abbvie Inc.	Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy
US9656955B2 (en)	2013-03-15	2017-05-23	Abbvie Inc.	Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy
WO2015055770A1 (en)	2013-10-17	2015-04-23	AbbVie Deutschland GmbH & Co. KG	Aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives, pharmaceutical compositions containing them, and their use in therapy
KR20160062165A (ko)	2013-10-17	2016-06-01	아비에 도이치란트 게엠베하 운트 콤파니 카게	아미노테트랄린 및 아미노인단 유도체, 이들을 포함하는 약제학적 조성물, 및 치료에서 이들의 용도
US9550754B2 (en)	2014-09-11	2017-01-24	AbbVie Deutschland GmbH & Co. KG	4,5-dihydropyrazole derivatives, pharmaceutical compositions containing them, and their use in therapy

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5254569A (en) *	1991-01-14	1993-10-19	The Du Pont Merck Pharmaceutical Company	(Amidomethyl)nitrogen heterocyclic analgesics
JP3026845B2 (ja) *	1991-02-20	2000-03-27	日清製粉株式会社	ピペリジン誘導体
SK13092000A3 (sk) *	1998-03-06	2001-03-12	Janssen Pharmaceutica N. V.	Inhibítory prenosu glycínu, spôsob ich prípravy, farmaceutický prostriedok s ich obsahom a ich použitie
FR2838739B1 (fr) *	2002-04-19	2004-05-28	Sanofi Synthelabo	Derives de n-[phenyl(piperidin-2-yl)methyl)benzamide, leur preparation et leur application en therapeutique
FR2842804B1 (fr) *	2002-07-29	2004-09-03	Sanofi Synthelabo	Derives de n-[phenyl(piperidin-2-yl)methyl]benzamide, leur preparation et leur application en therapeutique
TW200526626A (en) *	2003-09-13	2005-08-16	Astrazeneca Ab	Chemical compounds
FR2861070B1 (fr)	2003-10-17	2006-01-06	Sanofi Synthelabo	Derives de n-[phenyl(pyrrolidin-2-yl)methyl]benzamide et n-[(azepan-2-yl)phenylmethyl]benzamide, leur preparation et leur application en therapeutique
AU2006235400A1 (en) *	2005-04-11	2006-10-19	Yale University	Method of treating schizophrenia prodrome

2003
- 2003-10-17 FR FR0312143A patent/FR2861070B1/fr not_active Expired - Fee Related
2004
- 2004-10-15 DE DE602004006891T patent/DE602004006891T2/de active Active
- 2004-10-15 RU RU2006116890/04A patent/RU2386614C2/ru not_active IP Right Cessation
- 2004-10-15 ES ES04791555T patent/ES2286689T3/es active Active
- 2004-10-15 EP EP04791555A patent/EP1680400B1/fr active Active
- 2004-10-15 PL PL04791555T patent/PL1680400T3/pl unknown
- 2004-10-15 NZ NZ547167A patent/NZ547167A/en not_active IP Right Cessation
- 2004-10-15 ZA ZA200603862A patent/ZA200603862B/en unknown
- 2004-10-15 DK DK04791555T patent/DK1680400T3/da active
- 2004-10-15 PT PT04791555T patent/PT1680400E/pt unknown
- 2004-10-15 AT AT04791555T patent/ATE364038T1/de active
- 2004-10-15 WO PCT/FR2004/002644 patent/WO2005037785A2/fr active IP Right Grant
- 2004-10-15 JP JP2006534801A patent/JP4700007B2/ja not_active Expired - Fee Related
- 2004-10-15 ME MEP-126/08A patent/MEP12608A/hr unknown
- 2004-10-15 AU AU2004281218A patent/AU2004281218B2/en not_active Ceased
- 2004-10-15 CN CNA2004800338510A patent/CN1882534A/zh active Pending
- 2004-10-15 RS YUP-2006/0315A patent/RS20060315A/sr unknown
- 2004-10-15 BR BRPI0415511-4A patent/BRPI0415511A/pt not_active IP Right Cessation
- 2004-10-15 CA CA002542727A patent/CA2542727A1/fr not_active Abandoned
2006
- 2006-04-11 IL IL174934A patent/IL174934A/en not_active IP Right Cessation
- 2006-04-17 US US11/405,191 patent/US7226917B2/en not_active Expired - Fee Related
- 2006-04-17 MA MA28943A patent/MA28098A1/fr unknown
- 2006-05-05 NO NO20062032A patent/NO20062032L/no not_active Application Discontinuation
2007
- 2007-04-30 US US11/741,803 patent/US7700585B2/en not_active Expired - Fee Related
- 2007-07-11 HR HR20070307T patent/HRP20070307T3/hr unknown
- 2007-08-31 CY CY20071101114T patent/CY1106827T1/el unknown

Also Published As

Publication number	Publication date
DE602004006891D1 (de)	2007-07-19
EP1680400B1 (fr)	2007-06-06
US20060223802A1 (en)	2006-10-05
FR2861070B1 (fr)	2006-01-06
DE602004006891T2 (de)	2008-01-31
ZA200603862B (en)	2007-11-28
RS20060315A (en)	2008-11-28
BRPI0415511A (pt)	2006-12-12
FR2861070A1 (fr)	2005-04-22
CY1106827T1 (el)	2012-05-23
PL1680400T3 (pl)	2007-11-30
CA2542727A1 (fr)	2005-04-28
MA28098A1 (fr)	2006-08-01
IL174934A (en)	2011-01-31
US7226917B2 (en)	2007-06-05
DK1680400T3 (da)	2007-09-10
US20070208006A1 (en)	2007-09-06
EP1680400A2 (fr)	2006-07-19
CN1882534A (zh)	2006-12-20
RU2006116890A (ru)	2007-11-27
JP2007508362A (ja)	2007-04-05
RU2386614C2 (ru)	2010-04-20
AU2004281218B2 (en)	2011-02-10
ES2286689T3 (es)	2007-12-01
WO2005037785A2 (fr)	2005-04-28
WO2005037785A3 (fr)	2005-07-14
NZ547167A (en)	2009-11-27
AU2004281218A1 (en)	2005-04-28
ATE364038T1 (de)	2007-06-15
IL174934A0 (en)	2006-08-20
PT1680400E (pt)	2007-07-24
JP4700007B2 (ja)	2011-06-15
HRP20070307T3 (hr)	2007-09-30
NO20062032L (no)	2006-07-10
US7700585B2 (en)	2010-04-20

Publication	Publication Date	Title
MEP12608A (hr)	2010-06-10	N-(fenil (2-pirodinil) benzamid i n-(2-azepanil) fenil metil/benzamid derivati, njihovo dobijanje i terapeutska primjena
MEP22008A (en)	2010-06-10	Derivatives of n-[heteroaryl(piperidine-2-yl)methyl]benzamide, preparation method thereof and application of same in therapeutics
MEP12708A (en)	2010-06-10	Derivatives of n-[phenyl (alkylpiperidine-2-yl) methyl]benzamide, preparation method thereof and application of same in therapeutics
MEP25608A (en)	2010-06-10	Derivatives of n-[phenyl(piperidin-2-yl)methyl]benzamide, the preparation method thereof and application of same in therapeutics
RS53588B1 (en)	2015-02-27	COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS
WO2004013101A3 (fr)	2004-05-13	Derives de n-[phenyl(piperidin-2-yl)methyl]benzamide, leur preparation et leur application en therapeutique
HRP20050682B1 (hr)	2014-09-12	Derivati pirazolopiridina
DE60208568D1 (de)	2006-03-30	Prostaglandinanaloga als ep4-rezeptoragonisten
HUP0300527A2 (hu)	2003-07-28	Pirrolopirimidinon-származékok, a vegyületek előállítása és alkalmazása
DK1414302T3 (da)	2007-06-18	7-aminotriazolopyrimidiner til bekæmpelse af skadelige svampe
NO331165B1 (no)	2011-10-24	Derivater av dioksan-2-alkylkarbamater, fremgangsmate for fremstilling derav og anvendelse av de samme for fremstilling av medikamenter
DE602005022764D1 (de)	2010-09-16	Piperidin- und azetidinderivate als glyt1-inhibitoren
NO20025641D0 (no)	2002-11-22	Substituerte 1-aminoalkyl-laktamer og deres anvendelse som muscarin-reseptor-antagonister
CY1116183T1 (el)	2017-02-08	Πιπεραζινοδιονες ως ανταγωνιστες υποδοχεα οξυτοκινης
RS50853B (sr)	2010-08-31	Derivati n-(1h-indolil)-1h-indol-2-karboksamida, njihova priprema i njihova primena u terapiji
NO20063330L (no)	2006-09-14	Amidderivater med en syklopropylaminokarbonylsubstituent som er nyttige som cytokininhibitorer
WO2009118473A3 (fr)	2009-11-19	Composés dérivés d'azétidines, leur préparation et leur application en thérapeutique
SE0403171D0 (sv)	2004-12-23	New compounds
NO20025640D0 (no)	2002-11-22	Substituerte 1-aminoalkyl-laktamer og deres anvendelse som muscarin-reseptor-antagonister
AR041246A1 (es)	2005-05-11	Derivados de piridina; un procedimiento de preparacion de los mismos y composicion farmaceutica que los contiene
HRP20080363T3 (hr)	2008-09-30	Piridin-4-il-etinil-imidazoli i pirazoli kao antagonisti mglu5 receptora
MY146939A (en)	2012-10-15	Derivatives of 7-alkynyl-1,8-naphthyridones, preparation method thereof and use of same in therapeutics
HRP20080173T3 (hr)	2008-06-30	DERIVATI IMIDAZOLA I NJIHOVA UPOTREBA U LIJEČENJUPOREMEĆAJA POSREDOVANIH mGluR5 RECEPTOROM
ATE274518T1 (de)	2004-09-15	6-(2-chlor-6-fluor-phenyl)-triazolpyrimidine
NO20064073L (no)	2006-11-06	Derivater fra 2H- eller 3H-benzo[e]indazol-1-yl-karbamat, deres fremstilling og terapeutisk anvendelse derav